Racial differences and other risk factors for incidence and progression of age-related macular degeneration: Salisbury Eye Evaluation (SEE) Project

Investigative Ophthalmology and Visual Science

Volumn 49, Issue 6, 2008, Pages 2395-2402

  Chang, Margaret A ^a   Bressler, Susan B ^a   Munoz, Beatriz ^a   West, Sheila K ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ATROPHY; CLINICAL EXAMINATION; DISEASE COURSE; DOSE RESPONSE; DRUSEN; EYE PHOTOGRAPHY; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OPHTHALMOSCOPY; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RACE DIFFERENCE; READING; RETINA FOVEA; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA LUTEA; RISK FACTOR; SMOKING; AFRICAN AMERICAN; CAUCASIAN; ETHNOLOGY; PATHOPHYSIOLOGY; RETINA MACULA DEGENERATION; STATISTICS; UNITED STATES;

AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INCIDENCE; MACULAR DEGENERATION; MALE; MARYLAND; RISK FACTORS; SMOKING;

EID: 47249108083     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.07-1584     Document Type: Article

References (43)

1. Congdon N, O'Colmain B, Klaver CC, et al. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 2004;122:477-485. (Pubitemid 38456282)
2. Bressler NM, Bressler SB, Congdon NG, et al. Potential public health impact of Age-Related Eye Disease Study results: AREDS report no. 11. Arch Ophthalmol. 2003;121:1621-1624. (Pubitemid 37392370)
3. Edwards AO, Ritter R 3rd, Abel KJ, et al. Complement factor H polymorphism and age-related macular degeneration. Science. 2005;308:421-424.
4. Haines JL, Hauser MA, Schmidt S, et al. Complement factor H variant increases the risk of age-related macular degeneration. Science. 2005;308:419-421. (Pubitemid 40530081)
5. Klein RJ, Zeiss C, Chew EY, et al. Complement factor H polymorphism in age-related macular degeneration. Science. 2005;308:385-389. (Pubitemid 40530070)
6. Mitchell P, Wang JJ, Smith W, Leeder SR. Smoking and the 5-year incidence of age-related maculopathy: the Blue Mountains Eye Study. Arch Ophthalmol. 2002;120:1357-1363. (Pubitemid 36105441)
7. Vingerling JR, Hofman A, Grobbee DE, de Jong PT. Age-related macular degeneration and smoking. The Rotterdam Study. Arch Ophthalmol. 1996;114:1193-1196. (Pubitemid 26338849)
8. Smith W, Mitchell P, Leeder SR. Smoking and age-related maculopathy. The Blue Mountains Eye Study. Arch Ophthalmol. 1996;114:1518-1523. (Pubitemid 26406270)
9. Klein R, Klein BE, Linton KL, DeMets DL. The Beaver Dam Eye Study: the relation of age-related maculopathy to smoking. Am J Epidemiol. 1993;137:190-200. (Pubitemid 23083671)
10. Clemons TE, Milton RC, Klein R, et al. Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS). AREDS report no. 19. Ophthalmology. 2005;112:533-539. (Pubitemid 41108849)
11. Thornton J, Edwards R, Mitchell P, Harrison RA, Buchan I, Kelly SP. Smoking and age-related macular degeneration: a review of association. Eye. 2005;19:935-944. (Pubitemid 43114972)
12. Age-Related Eye Disease Study Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. AREDS Report no. 8. Arch Ophthalmol. 2001;119:1417-1436. (Pubitemid 32963246)
13. Cruickshanks KJ, Klein R, Klein BE, Nondahl DM. Sunlight and the 5-year incidence of early age-related maculopathy: the Beaver Dam Eye Study. Arch Ophthalmol. 2001;119:246-250. (Pubitemid 32147933)
14. Klein R, Klein BE, Jensen SC. The relation of cardiovascular disease and its risk factors to the 5-year incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology. 1997;104:1804-1812. (Pubitemid 28100335)
15. Age-Related Eye Disease Study Group. Risk factors associated with age-related macular degeneration: a case-control study in the age-related eye disease study. Age-Related Eye Disease Study Report Number 3. Ophthalmology. 2000;107:2224-2232.
16. Wong TY, Klein R, Klein BE, Tomany SC. Refractive errors and 10-year incidence of age-related maculopathy. Invest Ophthalmol Vis Sci. 2002;43:2869-2873. (Pubitemid 34977034)
17. Ikram MK, van Leeuwen R, Vingerling JR, et al. Relationship between refraction and prevalent as well as incident age-related maculopathy: the Rotterdam Study. Invest Ophthalmol Vis Sci. 2003;44:3778-3782. (Pubitemid 37047946)
18. Wang JJ, Klein R, Smith W, et al. Cataract surgery and the 5-year incidence of late-stage age-related maculopathy: pooled findings from the Beaver Dam and Blue Mountains eye studies. Ophthalmology. 2003;110:1960-1967. (Pubitemid 37163314)
19. Klein R, Klein BE, Linton KL. Prevalence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology. 1992;99:933-943.
20. Schachat AP, Hyman L, Leske MC, et al. Features of age-related macular degeneration in a black population: the Barbados Eye Study Group. Arch Ophthalmol. 1995;113:728-735.
21. West SK, Duncan DD, Munoz B, et al. Sunlight exposure and risk of lens opacities in a population-based study: the Salisbury Eye Evaluation project. JAMA. 1998;280:714-718. (Pubitemid 28405296)
22. Duncan DD, Munoz B, Bandeen-Roche K, West SK. Visible and ultraviolet-B ocular-ambient exposure ratios for a general population: Salisbury Eye Evaluation Project Team. Invest Ophthalmol Vis Sci. 1997;38:1003-1011.
23. Bressler SB, Munoz B, Solomon S, West SK and the Salisbury Eye Evaluation (SEE) Study Team. The prevalence of age-related macular degeneration and fundus characteristics of AMD in blacks and whites: the Salisbury Eye Evaluation (SEE) Project. Arch Ophthalmol. 2008;126:241-245.
24. Davis MD, Gangnon RE, Lee LY, et al. The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17. Arch Ophthalmol. 2005;123:1484-1498. (Pubitemid 41626684)
25. Ferris FL, Davis MD, Clemons TE, et al. A simplified severity scale for age-related macular degeneration: AREDS Report No. 18. Arch Ophthalmol. 2005;123:1570-1574. (Pubitemid 41626694)
26. Klein R, Klein BE, Jensen SC, Meuer SM. The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology. 1997;104:7-21. (Pubitemid 27081937)
27. Smith W, Assink J, Klein R, et al. Risk factors for age-related macular degeneration: pooled findings from three continents. Ophthalmology. 2001;108:697-704. (Pubitemid 32238465)
28. Leske MC, Wu SY, Hennis A, et al. Nine-year incidence of agerelated macular degeneration in the Barbados Eye Studies. Ophthalmology. 2006;113:29-35. (Pubitemid 43021724)
29. Tomany SC, Wang JJ, Van Leeuwen R, et al. Risk factors for incident age-related macular degeneration: pooled findings from 3 continents. Ophthalmology. 2004;111:1280-1287. (Pubitemid 38844822)
30. Javitt JC, Zhou Z, Maguire MG, et al. Incidence of exudative age-related macular degeneration among elderly Americans. Ophthalmology. 2003;110:1534-1539. (Pubitemid 36962485)
31. Klein R, Klein BE, Wong TY, et al. The association of cataract and cataract surgery with the long-term incidence of age-related maculopathy: the Beaver Dam eye study. Arch Ophthalmol. 2002;120:1551-1558. (Pubitemid 36406433)
32. Klein R, Klein BE, Tomany SC, Moss SE. Ten-year incidence of age-related maculopathy and smoking and drinking: the Beaver Dam Eye Study. Am J Epidemiol. 2002;156:589-598.
33. Klein R, Klein BE, Tomany SC, Cruickshanks KJ. The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology. 2003;110:1273-1280. (Pubitemid 36520056)
34. Tomany SC, Cruickshanks KJ, Klein R, et al. Sunlight and the 10-year incidence of age-related maculopathy: the Beaver Dam Eye Study. Arch Ophthalmol. 2004;122:750-757. (Pubitemid 38596256)
35. Aiello LP, Northrup JM, Keyt BA, Takagi H, Iwamoto MA. Hypoxic regulation of vascular endothelial growth factor in retinal cells. Arch Ophthalmol. 1995;113:1538-1544.
36. Akishima S, Matsushita S, Sato F, et al. Cigarette-smoke-induced vasoconstriction of peripheral arteries: evaluation by synchrotron radiation microangiography. Circ J. 2007;71:418-422. (Pubitemid 46409548)
37. Lip PL, Blann AD, Hope-Ross M, Gibson JM, Lip GY. Age-related macular degeneration is associated with increased vascular endothelial growth factor, hemorheology and endothelial dysfunction. Ophthalmology. 2001;108:705-710. (Pubitemid 32238466)
38. Zarbin MA. Current concepts in the pathogenesis of age-related macular degeneration. Arch Ophthalmol. 2004;122:598-614. (Pubitemid 38456297)
39. Alberg A. The influence of cigarette smoking on circulating concentrations of antioxidant nutrients. Toxicology. 2002;180:121-137. (Pubitemid 35254069)
40. Sastry BV, Hemontolor ME. Influence of nicotine and cotinine on retinal phospholipase A2 and its significance to macular function. J Ocul Pharmacol Ther. 1998;14:447-458. (Pubitemid 28489687)
41. The Eye Disease Case-Control Study Group. Risk factors for neovascular age-related macular degeneration. The Eye Disease Case-Control Study Group. Arch Ophthalmol. 1992;110:1701-1708.
42. Jampol LM, Tielsch J. Race, macular degeneration, and the Macular Photocoagulation Study. Arch Ophthalmol. 1992;110:1699-1700.
43. Klein R, Klein BE, Knudtson MD, et al. Prevalence of age-related macular degeneration in 4 racial/ethnic groups in the multi-ethnic study of atherosclerosis. Ophthalmology. 2006;113:373-380. (Pubitemid 43296976)